|BIBCL -- India Stock|| |
INR 8.07 0.17 2.15%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Bharat Immunologicals Revenue Analysis
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Bharat Immunologicals ValuationFundamentalsBuy or Sell
|Bharat Immunologicals ||Revenue|| = |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd reported 836.45M of revenue. This is 89.03% lower than that of the Healthcare sector, and 12.59% higher than that of Biotechnology
industry, The Revenue for all stocks is 91.13% higher than the company.
Find insiders across different sectors to evaluate their impact on performance
Bharat Immunologicals current financial ratios